Objective:The postoperative survival rates of patients with gastric cancer at different stages treated at the National Cancer Center(NCC)of China have not been reported.Therefore,we evaluated the survival of patients ...Objective:The postoperative survival rates of patients with gastric cancer at different stages treated at the National Cancer Center(NCC)of China have not been reported.Therefore,we evaluated the survival of patients with gastric cancer who underwent surgery at the NCC from 2011 to 2018 to provide baseline information for further studies.Methods:We identified 7,301 patients with primary gastric carcinoma who underwent surgery at the NCC be-tween January 2011 and May 2018;among these,5,008 patients were enrolled in this study.Follow up was completed on April 30,2020.We analyzed the 5-year survival according to the stage,sex,age,and other clini-copathological features.Results:Five-year survival rates of patients with pTNM stages ⅠA,ⅠB,ⅡA,ⅡB,ⅢA,ⅢB,ⅢC,and Ⅳ treated at the NCC were 94.9%,91.8%,86.5%,76.1%,61.1%,44.2%,29.7%,and 8.1%,respectively,which were similar to those reported in Japan during the same period.Five-year survival rates of patients with ypTNM stages I,II,III,and IV were 93.1%,63.2%,27.2%,and 0.0%,respectively.In multivariable analysis,age,signet ring cell carcinoma,adjuvant chemotherapy,and degree of differentiation were revealed as important prognostic factors.Conclusion:The survival rates of patients with gastric cancer treated at the NCC have been significantly improved,reaching the levels of Japan in the same period.展开更多
Chinese medicine （CM） is an important feature of cancer treatment in China. Especially in the last 10 years, the effect of CM in cancer treatment has been of high concern and has been accepted by experts and patient...Chinese medicine （CM） is an important feature of cancer treatment in China. Especially in the last 10 years, the effect of CM in cancer treatment has been of high concern and has been accepted by experts and patients locally and overseas. The oncology department （OD） of Guang＇anmen Hospital （GAMH） of China Academy of Chinese Medical Sciences （CATCM）, which will mark its 50th anniversary in 2013, is one of China＇s most-respected centers devoted exclusively to cancer patient care, research, education, and prevention through CM. It is located at the campus of GAMH, central Beijing.展开更多
基金the National Central Cancer Registry for matching patient survival outcomessupported by National Natural Science Foundation of China(grant number 82072734).
文摘Objective:The postoperative survival rates of patients with gastric cancer at different stages treated at the National Cancer Center(NCC)of China have not been reported.Therefore,we evaluated the survival of patients with gastric cancer who underwent surgery at the NCC from 2011 to 2018 to provide baseline information for further studies.Methods:We identified 7,301 patients with primary gastric carcinoma who underwent surgery at the NCC be-tween January 2011 and May 2018;among these,5,008 patients were enrolled in this study.Follow up was completed on April 30,2020.We analyzed the 5-year survival according to the stage,sex,age,and other clini-copathological features.Results:Five-year survival rates of patients with pTNM stages ⅠA,ⅠB,ⅡA,ⅡB,ⅢA,ⅢB,ⅢC,and Ⅳ treated at the NCC were 94.9%,91.8%,86.5%,76.1%,61.1%,44.2%,29.7%,and 8.1%,respectively,which were similar to those reported in Japan during the same period.Five-year survival rates of patients with ypTNM stages I,II,III,and IV were 93.1%,63.2%,27.2%,and 0.0%,respectively.In multivariable analysis,age,signet ring cell carcinoma,adjuvant chemotherapy,and degree of differentiation were revealed as important prognostic factors.Conclusion:The survival rates of patients with gastric cancer treated at the NCC have been significantly improved,reaching the levels of Japan in the same period.
文摘Chinese medicine （CM） is an important feature of cancer treatment in China. Especially in the last 10 years, the effect of CM in cancer treatment has been of high concern and has been accepted by experts and patients locally and overseas. The oncology department （OD） of Guang＇anmen Hospital （GAMH） of China Academy of Chinese Medical Sciences （CATCM）, which will mark its 50th anniversary in 2013, is one of China＇s most-respected centers devoted exclusively to cancer patient care, research, education, and prevention through CM. It is located at the campus of GAMH, central Beijing.
